Form 4 for ELV Elevance Health
Accepted 2023-01-05 00:00:00 ET · period of report 2023-01-03 · accession 0001156039-23-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-05 | 2023-01-03 | ELV | Todt Blair Williams | EVP, CLO | A - Grant | $0.00 | +3,983 | 8,283 | +93% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-03 | A | A | 3,983 | $0.00 | 8,283 | D | — | — | (F1) Represents restricted share units. Restrictions lapse as follows: 1,327 shares on 1/3/2024, and 1,328 shares each on 1/3/2025 and 1/3/2026. |